Key result
Early cardiometabolic risk factors linked to gut microbiota fragmentation despite preserved overall diversity.
Why the study?
It is unclear whether gut microbiome compositional changes are a cause or consequence of cardiometabolic disease, as secondary large-scale shifts may obscure original microbial drivers.
Are specific gut microbial taxa and community associations altered in the early stages of cardiometabolic disease progression?
Cross-Sectional (n=132)
No
Are specific gut microbial taxa and community associations altered in the early stages of cardiometabolic disease progression?
The loss of health-associated gut microbiota and increased microbial network fragmentation may play a role in the early progression of cardiometabolic disease.
Answers are grounded in this paper and cite their sources.
CMD microbiome shifts may be consequential; leaves open whether specific taxa drive disease or serve as markers.
Purpose Individuals with cardiometabolic disease (CMD) often exhibit decreased microbial alpha diversity and/or differences in beta diversity indices than those without CMD. However, it is unclear if these compositional changes in the gut microbiome are a cause or a consequence of CMD. Research suggests individual bacterial species act as drivers of disease, inducing shifts in microbial community and host metabolism. During this process, large-scale compositional changes can develop secondarily, obscuring the original microbial drivers. This study aimed to characterize the gut microbiota of healthy individuals compared to those with early risk factors for CMD to determine whether specific microbial taxa and community associations exist with early stages of hypertension, vascular dysfunction, dyslipidemia, and overweight/obesity. Procedure Baseline anthropometric, physiological, and gut microbiome data from three clinical studies previously conducted by our research groups were compiled and re-analyzed. Results No differences in alpha and/or beta diversity were observed across CMD parameters. Through a consensus-based differential abundance analysis, we observed that several health-related taxa decreased as CMD levels increased, including Akkermansia, Bacteroides, Bifidobacterium, Blautia, Eubacterium, Lachnospiraceae, Oscillospiraceae, Prevotella, Roseburia, and Ruminococcus. Furthermore, co-occurrence networks of individuals with elevated cardiometabolic parameters showed lower clustering coefficients, higher path lengths, lower degrees, higher modularity, and higher negative cohesion than those with normal parameters. Implications The loss of health-associated gut microbiota, along with decreased network connectivity and increased network fragmentation, may play a role in the progression of CMD.
No takes yet. Share an insight, caveat, or question.
Wrigley et al. (2026) conducted a cross-sectional in Cardiometabolic disease risk factors (n=132). Early cardiometabolic risk factors vs. Normal cardiometabolic parameters was evaluated on Gut microbiota alpha and beta diversity, differential abundance of taxa, and co-occurrence network characteristics. Early cardiometabolic risk factors were associated with a loss of health-associated gut microbiota and increased microbial network fragmentation, despite no significant changes in overall alpha or beta diversity.
Synapse has enriched 10 related papers. Consider them for comparative context: